Garon, Michela http://orcid.org/0000-0003-4945-5498
Weis, Luca http://orcid.org/0000-0002-2286-0795
Siquier, Antònia http://orcid.org/0000-0003-4062-6422
Fiorenzato, Eleonora http://orcid.org/0000-0001-7947-5903
Pistonesi, Francesca
Cianci, Valeria
Canesi, Margherita http://orcid.org/0000-0002-2642-6195
Pesce, Francesca http://orcid.org/0000-0003-3873-7203
Reali, Elisa
Pozzi, Beatrice http://orcid.org/0000-0002-2507-700X
Isaias, Ioannis Ugo http://orcid.org/0000-0002-3552-5144
Siri, Chiara http://orcid.org/0000-0002-9199-4084
Santangelo, Gabriella http://orcid.org/0000-0002-7728-852X
Cuoco, Sofia http://orcid.org/0000-0002-5755-4544
Barone, Paolo http://orcid.org/0000-0001-8965-2504
Kulisevsky, Jaime http://orcid.org/0000-0003-4870-1431
Antonini, Angelo http://orcid.org/0000-0003-1040-2807
Biundo, Roberta http://orcid.org/0000-0001-5846-755X
Funding for this research was provided by:
Ministero della Salute (GR-2016-02361986)
Università degli Studi di Padova
Article History
Received: 9 December 2023
Accepted: 16 January 2024
First Online: 27 January 2024
Declarations
:
: The authors declare that there are no conflicts of interest relevant to this work. Dr. Kulisevsky has received grants and Institutional support from Instituto de Salud Carlos III, Ciberned and AGAUR (Spain) and economic compensation for advisory boards or lectures from Zambon, Esteve, Abbvie, UCB, Teva, and BIAL. Prof Paolo Barone received consultancies as a member of the advisory board for Zambon, Lundbeck, UCB, Chiesi, Abbvie, and Acorda. Prof. Angelo Antonini has received compensation for consultancy and speaker-related activities from UCB, Britannia, AbbVie, Zambon, Bial, Ever Pharma, Theravance Biopharma, Roche, General Electric, Medscape. He receives research support from Chiesi Pharmaceuticals, Lundbeck, Bial, Movement Disorders Society, Horizon2020 Grant 825785, Horizon2020 Grant 101016902, Ministry of Education University and Research (MIUR) Grant ARS01_01081. The other authors declare that there are no additional disclosures to report.
: We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.